
Inflexion-backed Phenna Group preps sale in Houlihan Lokey-led process
Inflexion-backed testing and business services provider Phenna Group is preparing a sale process, four sources familiar with the matter said.
Houlihan Lokey is mandated for the auction for the UK-based testing, inspection, certification and compliance (TICC) business, three of the sources said. The company is expected to be marketed off GBP 60m EBITDA, two of the sources said.
Sponsors are circling the asset, attracted to its underlying resilience, two of the sources said. The vendor is already engaged in conversations with selected parties, one of the sources said, with another adding that a process could launch in September.
The rapid growth story however triggers question marks around how integrated the platform really is, one of the sources cautioned.
Inflexion acquired a minority stake in Phenna Group in November 2020 through its Partnership Capital II fund, following the company’s MBO, with debt provided by CVC Credit Partners, in April 2019.
Phenna has since engaged in significant buy-and-build, with deals including the acquisition of A-Star Group in February this year, the acquisition of James Fisher Testing Services from James Fisher and Sons in November 2021, the acquisition of Facit Testing in February 2021 and the acquisition of three divisions from Bolton NDT & Inspection in January 2021.
In 2020, Phenna also acquired Approval Specialists Group, Build Check Group, Code a Weld Group, Starpoint Group, ASM Group, GSTL Group, Elmhurst Energy and Corporate Access Group among others, according to a Companies House filing.
Phenna Group comprises a range of TICC businesses spanning industrial manufacturing, built environments, construction, property, chemicals and pharmaceuticals, with numerous subsidiaries operating under the Phenna Group umbrella, according to its website.
Phenna Group, Inflexion and Houlihan Lokey declined to comment.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater